EDP Biotech Corporation is a privately held medical device company focused on the development and commercialization of blood based immunodiagnostic assays. During this unprecedented pandemic, EDP uses its blood-test technology and partnerships to bring FASTER COVID-19 diagnostic and serology testing as businesses and schools open across the Southeast US. Contact us for more details and to schedule your B2B consultation for testing services. EDP's first commercially focused oncology product, ColoPlex™, is a unique multiplex assay to be used in the early detection of colorectal cancer and pre-cancerous polyps.